NCT06799026 2025-09-02A Phase 1 Study of Vaccination With Dendritic Cell (DC)/Multiple Myeloma (MM) Fusions in Combination With Elranatamab in Relapsed or Refractory Multiple MyelomaBeth Israel Deaconess Medical CenterPhase 1 Recruiting25 enrolled